Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot84484 captures any quantitative troponin assay that reports a numeric concentration from serum or plasma. There is no separate CPT code distinguishing troponin I from troponin T at the quantitative assay level; both isoforms measured quantitatively are reported with 84484 [2]. The ACC/AHA 2021 Chest Pain Guideline designates high-sensitivity cardiac troponin (hs-cTn) as the preferred biomarker for ACS evaluation, recommending Class I serial algorithms at 0/1h or 0/2h for early NSTEMI rule out [1]. As of CPT 2026, no distinct code has been established to separate high-sensitivity from conventional troponin assays; both are reported with 84484 [2].
Primary clinical indications:
The code selection criterion is result format, not device type or clinical setting: a numeric concentration in any unit (ng/mL, pg/mL, etc.) equals 84484; a binary positive/negative result equals 84512. This applies whether the analyzer is in a hospital core laboratory, a clinic, or a point-of-care device.
| Code | Description | When to Use Instead |
|---|---|---|
| 84484 | Troponin, quantitative | Any numeric concentration result (ng/mL, pg/mL) for any clinical indication |
| 84512 | Troponin, qualitative | Point-of-care device reports positive/negative only; result is not a numeric value |
| 82553 | Creatine kinase (CK), MB fraction | CK-MB ordered alongside troponin for timing differentiation or protocol; separately billable |
| 83880 | Natriuretic peptide (BNP/NT-proBNP) | Dyspnea evaluation to differentiate heart failure from ACS; separately billable |
| 83874 | Myoglobin | Early rising cardiac marker ordered as adjunct; less specific than troponin |
The critical differentiator between 84484 and 84512 is the assay result format alone. A bedside analyzer that generates a numeric troponin value is 84484 even if used at a small clinic or urgent care; a lateral flow strip that returns "POSITIVE" is 84512 even if performed in a hospital emergency department. Billing 84484 when the result is qualitative misrepresents the service performed.
Modifier 91 (Repeat Clinical Diagnostic Laboratory Test): When 84484 is ordered multiple times on the same date, each repeat draw intended to generate independent clinical results requires Modifier 91 on the second and any subsequent units [3]. Modifier 91 is not appropriate when a repeat is performed to confirm an initial result due to equipment malfunction, specimen quality issues, or any quality control purpose. It is inapplicable when another code inherently describes a series of results (not applicable here). The modifier applies only to laboratory tests performed more than once on the same calendar date for the same patient [3].
MUE = 2: Medicare allows a maximum of 2 units of 84484 per claim line per date of service [5]. This ceiling aligns with the standard 0h/3h serial protocol. If a three-draw protocol (0h/3h/6h) is clinically documented, the third unit will trigger automated MUE review; coders should consult MAC-specific guidance on whether line-level MUE versus date-of-service MUE applies and whether separate line submission with draw times supports additional payment.
Modifier 90 (Reference Laboratory): Append Modifier 90 when the billing provider collects the specimen but sends it to an outside reference laboratory for analysis. Modifier 90 is uncommon for stat troponin (typically performed in house) but applies in settings without on-site laboratory capability.
Modifier 26/TC: PC/TC indicator = 9 for 84484; professional and technical components are not separately reportable. Do not append Modifier 26 or TC to chemistry analyte codes.
Modifier QW (CLIA Waived): 84484 is not CLIA waived [8]. Do not append QW. For qualitative troponin on a CLIA-waived device, use 84512 with Modifier QW after verifying the specific device's waived status on the CDC CLIA waived test list [9].
Venipuncture: Specimen collection (36415) is separately reportable and is not bundled with chemistry analyte codes [2].
NCCI PTP edits: 84484 has limited procedure-to-procedure bundling exposure as a standalone analyte code. It is not bundled into a comprehensive metabolic panel or cardiac panel in standard CPT. Verify current-quarter PTP edit tables for any new edit pairs [4].
For each unit of 84484 billed, the medical record must support:
Audit red flags specific to 84484:
Medicare:
84484 is paid under the CLFS, not the MPFS [7]. The Statutory Exclusion status means no geographic GPCI adjustment applies; payment is uniform nationally. There is no National Coverage Determination specific to troponin testing [6]; coverage is adjudicated under the general laboratory medical necessity standard (SSA 1862(a)(1)(A)). Individual MACs may publish LCDs or Articles covering cardiac biomarker testing; verify the applicable MAC portal for jurisdiction-specific guidance before assuming coverage.
In hospital outpatient settings, the APC Status Indicator "Conditionally packaged laboratory tests" means 84484 may not be separately payable when performed on the same day as a significant diagnostic or surgical procedure under OPPS packaging rules. This is an expected OPPS policy outcome, not a billing error. Independent laboratories and physician offices are not subject to APC packaging.
MUE = 2 is enforced by Medicare automated edits at the claim line level [5]. Appeals for additional units require medical record documentation supporting each draw independently.
Commercial Payers:
Commercial payer policies generally align with Medicare's medical necessity standard for troponin, but prior authorization requirements, diagnosis restrictions, and unit limits vary by plan. The high frequency of Modifier 90 usage in 84484 claims (approximately 62% per modifier utilization data) indicates that reference laboratory billing is common for this code; plan-specific reference laboratory policies and network status directly affect payment. Some commercial payers bundle serial troponin draws into an emergency department visit payment; verify the applicable plan's laboratory policy before assuming separate payment for each unit.
Medicaid:
State Medicaid programs and managed Medicaid plans vary in laboratory fee schedule rates and serial draw coverage. Some states require prior authorization for repeated inpatient laboratory testing. No uniform federal Medicaid coverage standard applies to 84484 specifically; verify the applicable state or managed care plan policy.
Duplicate claim denial (Modifier 91 missing) When 84484 is billed twice on the same date without Modifier 91, payer systems flag the second unit as a duplicate claim submission. This is the most common denial pattern for serial troponin protocols. Prevention: Append Modifier 91 to the second and any subsequent unit of 84484 on the same date. The clinical note must document the reason for each repeat draw; "serial troponin per protocol" is sufficient only when supported by patient-specific context.
MUE exceeded (more than 2 units) Billing three or more units of 84484 on the same date triggers automatic denial under the Medicare MUE = 2 limit [5]. Prevention: If a three-draw protocol is clinically documented, consult MAC-specific guidance on line-level versus date-of-service MUE adjudication. Denials may be appealed with documentation showing the specific draw times and independent clinical necessity for each specimen.
Medical necessity denial (unsupported diagnosis) Claims submitted with diagnosis codes that do not support troponin testing (e.g., chronic musculoskeletal pain only) are denied under general lab medical necessity rules [3]. Prevention: The primary diagnosis on the claim should reflect the indication for the troponin order. Use presenting symptom codes (e.g., R07.9 for chest pain, unspecified) when a definitive diagnosis has not been established at the time of ordering.
Incorrect code selection (84484 vs 84512) Defaulting to 84484 for all troponin tests, including qualitative point-of-care devices that report positive/negative only, results in misrepresentation of the service performed. Prevention: Verify the laboratory report format before code selection. A numeric value in any unit confirms 84484. A binary result confirms 84512.
CLIA certificate mismatch Billing 84484 from a facility holding only a Certificate of Waiver is improper; quantitative troponin requires moderate or high complexity CLIA certification [8]. Prevention: Confirm the performing laboratory's CLIA certificate type before billing. Certificate of Waiver facilities are limited to CLIA-waived tests only. Standard quantitative troponin analyzers require a Certificate of Compliance or Accreditation.
Scenario 1: Emergency Department Serial Troponin, ACS Rule Out
A 58-year-old presents to the emergency department with substernal chest pain and diaphoresis. The physician orders a troponin per the ACS protocol; two quantitative draws are performed at 0 hours and 3 hours, returning 0.02 ng/mL (normal) and 0.18 ng/mL (elevated), prompting an NSTEMI diagnosis.
Correct coding: 84484 x 2 units; Modifier 91 on the second unit; ICD-10-CM I24.9 (NSTEMI, after second draw confirms) or R07.9 for the initial presentation.
Why: Both draws return numeric concentrations; 84484 is correct for both. Modifier 91 on the second unit signals an intentional repeat for independent clinical results and prevents a duplicate-claim denial. MUE = 2 is satisfied without additional documentation.
Scenario 2: Point-of-Care Qualitative Troponin at a Rural Clinic
A rural urgent care clinic uses a lateral flow point-of-care device that reports troponin as "POSITIVE" or "NEGATIVE" only. The device is listed on the CMS CLIA waived test list. A patient presents with atypical chest pain and the test returns "NEGATIVE."
Correct coding: 84512 with Modifier QW; ICD-10-CM R07.9.
Why: The result is qualitative (positive/negative), not a numeric concentration, so 84484 is incorrect. Modifier QW is appropriate only because this specific device holds CLIA-waived status confirmed on the CDC waived test list [9]; verify the device before appending QW.
Scenario 3: Inpatient Myocarditis Workup with Multiple Cardiac Biomarkers
A 32-year-old is admitted with chest pain, ST-segment changes, and fever. Troponin, CK-MB, and BNP are ordered to differentiate myocarditis from ACS. Results: troponin 2.4 ng/mL, CK-MB 18 ng/mL, BNP 310 pg/mL.
Correct coding: 84484 (troponin, quantitative); 82553 (CK-MB fraction); 83880 (natriuretic peptide); ICD-10-CM I40.9 (acute myocarditis, unspecified).
Why: Each analyte is a distinct reportable code; no NCCI PTP edit bundles these together [4]. Each requires its own medical necessity documentation in the order and clinical note.
Scenario 4: Post-CABG Troponin for Perioperative Cardiac Monitoring
On post-operative day 2 after CABG, a patient develops hypotension. The attending cardiologist orders a single troponin to evaluate for perioperative myocardial injury. Result: 4.1 ng/mL. No serial draw is ordered.
Correct coding: 84484 x 1 unit; ICD-10-CM I97.190 (other intraoperative cardiac functional disturbances) or applicable postoperative complication code. No Modifier 91 (single draw).
Why: The clinical note must document the specific concern prompting the order (hypotension with clinical concern for perioperative MI), not a generic "routine post-op labs" entry. Routine postoperative troponin without documented clinical indication does not meet medical necessity and is a recognized audit target for cardiac biomarker testing [10].
© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 84484 refers to a quantitative measurement of troponin levels in the blood. Troponins are a group of proteins found in cardiac and skeletal muscle that play a crucial role in muscle contraction by forming calcium bonds. Specifically, Troponin T is responsible for binding to tropomyosin, forming a complex that is essential for muscle function, while Troponin I binds to actin, stabilizing the Troponin T-tropomyosin complex. The measurement of troponin levels is particularly significant in the context of cardiac health, as elevated troponin levels, when accompanied by symptoms such as chest pain, are indicative of cardiac injury, including conditions like myocardial infarction (heart attack). This test is frequently utilized in emergency settings, especially in the Emergency Department, where it is often ordered for patients presenting with potential myocardial infarction. The troponin test is typically repeated at intervals of six hours to monitor changes in troponin levels over time. Additionally, it may be ordered alongside other cardiac biomarker tests, such as creatine kinase (CK), CK-MB, and myoglobin, to provide a comprehensive assessment of cardiac function. The blood sample for this test is obtained through a venipuncture, which is a separately reportable procedure. The analysis of the serum or plasma involves testing for Troponin T using a quantitative electrochemiluminescent immunoassay, while Troponin I is measured using a chemiluminescent immunoassay.
© Copyright 2026 Coding Ahead. All rights reserved.
The troponin quantitative test (CPT® Code 84484) is indicated for the following conditions:
The procedure for obtaining a troponin quantitative test involves several key steps:
After the troponin test is performed, the patient may be monitored for any immediate reactions to the venipuncture. The results of the troponin test are typically available within a short timeframe, allowing for timely clinical decision-making. If elevated troponin levels are detected, further evaluation and management of the patient's cardiac condition may be initiated. It is important to note that the troponin test may be repeated at six-hour intervals to track changes in troponin levels, which can provide valuable insights into the progression or resolution of cardiac injury. Additionally, healthcare providers may consider the troponin results in conjunction with other cardiac biomarkers and clinical findings to formulate a comprehensive treatment plan.
| Short Descr | ASSAY OF TROPONIN QUANT | Medium Descr | ASSAY OF TROPONIN QUANTITATIVE | Long Descr | Troponin, quantitative | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 2 | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | 26 | Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number. | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | Q4 | Service for ordering/referring physician qualifies as a service exemption | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | XE | Separate encounter, a service that is distinct because it occurred during a separate encounter | 77 | Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service. | CR | Catastrophe/disaster related | GA | Waiver of liability statement issued as required by payer policy, individual case | 76 | Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service. | Q1 | Routine clinical service provided in a clinical research study that is in an approved clinical research study | GW | Service not related to the hospice patient's terminal condition | X5 | Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician | PD | Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days | AY | Item or service furnished to an esrd patient that is not for the treatment of esrd | CS | Cost-sharing waived for specified covid-19 testing-related services that result in and order for or administration of a covid-19 test and/or used for cost-sharing waived preventive services furnished via telehealth in rural health clinics and federally qualified health centers during the covid-19 public health emergency | GC | This service has been performed in part by a resident under the direction of a teaching physician | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit | GZ | Item or service expected to be denied as not reasonable and necessary | PO | Excepted service provided at an off-campus, outpatient, provider-based department of a hospital | Q5 | Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area | Q6 | Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area | RT | Right side (used to identify procedures performed on the right side of the body) | SA | Nurse practitioner rendering service in collaboration with a physician | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2013-01-01 | Changed | Medium Descriptor changed. |
| 2011-01-01 | Changed | Short description changed. |
| 1997-01-01 | Added | First appearance in code book in 1997. |
Get instant expert-level medical coding assistance.